Laboratory Corporation of America Holdings
NYSE:LH

Watchlist Manager
Laboratory Corporation of America Holdings Logo
Laboratory Corporation of America Holdings
NYSE:LH
Watchlist
Price: 239.67 USD -0.21% Market Closed
Market Cap: 20B USD
Have any thoughts about
Laboratory Corporation of America Holdings?
Write Note

Intrinsic Value

The intrinsic value of one LH stock under the Base Case scenario is 259.89 USD. Compared to the current market price of 239.67 USD, Laboratory Corporation of America Holdings is Undervalued by 8%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LH Intrinsic Value
259.89 USD
Undervaluation 8%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Laboratory Corporation of America Holdings

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for LH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about LH?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Laboratory Corporation of America Holdings

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Laboratory Corporation of America Holdings

Provide an overview of the primary business activities
of Laboratory Corporation of America Holdings.

What unique competitive advantages
does Laboratory Corporation of America Holdings hold over its rivals?

What risks and challenges
does Laboratory Corporation of America Holdings face in the near future?

Summarize the latest earnings call
of Laboratory Corporation of America Holdings.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Laboratory Corporation of America Holdings.

Provide P/S
for Laboratory Corporation of America Holdings.

Provide P/E
for Laboratory Corporation of America Holdings.

Provide P/OCF
for Laboratory Corporation of America Holdings.

Provide P/FCFE
for Laboratory Corporation of America Holdings.

Provide P/B
for Laboratory Corporation of America Holdings.

Provide EV/S
for Laboratory Corporation of America Holdings.

Provide EV/GP
for Laboratory Corporation of America Holdings.

Provide EV/EBITDA
for Laboratory Corporation of America Holdings.

Provide EV/EBIT
for Laboratory Corporation of America Holdings.

Provide EV/OCF
for Laboratory Corporation of America Holdings.

Provide EV/FCFF
for Laboratory Corporation of America Holdings.

Provide EV/IC
for Laboratory Corporation of America Holdings.

Show me price targets
for Laboratory Corporation of America Holdings made by professional analysts.

What are the Revenue projections
for Laboratory Corporation of America Holdings?

How accurate were the past Revenue estimates
for Laboratory Corporation of America Holdings?

What are the Net Income projections
for Laboratory Corporation of America Holdings?

How accurate were the past Net Income estimates
for Laboratory Corporation of America Holdings?

What are the EPS projections
for Laboratory Corporation of America Holdings?

How accurate were the past EPS estimates
for Laboratory Corporation of America Holdings?

What are the EBIT projections
for Laboratory Corporation of America Holdings?

How accurate were the past EBIT estimates
for Laboratory Corporation of America Holdings?

Compare the revenue forecasts
for Laboratory Corporation of America Holdings with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Laboratory Corporation of America Holdings and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Laboratory Corporation of America Holdings against its competitors.

Analyze the profit margins
(gross, operating, and net) of Laboratory Corporation of America Holdings compared to its peers.

Compare the P/E ratios
of Laboratory Corporation of America Holdings against its peers.

Discuss the investment returns and shareholder value creation
comparing Laboratory Corporation of America Holdings with its peers.

Analyze the financial leverage
of Laboratory Corporation of America Holdings compared to its main competitors.

Show all profitability ratios
for Laboratory Corporation of America Holdings.

Provide ROE
for Laboratory Corporation of America Holdings.

Provide ROA
for Laboratory Corporation of America Holdings.

Provide ROIC
for Laboratory Corporation of America Holdings.

Provide ROCE
for Laboratory Corporation of America Holdings.

Provide Gross Margin
for Laboratory Corporation of America Holdings.

Provide Operating Margin
for Laboratory Corporation of America Holdings.

Provide Net Margin
for Laboratory Corporation of America Holdings.

Provide FCF Margin
for Laboratory Corporation of America Holdings.

Show all solvency ratios
for Laboratory Corporation of America Holdings.

Provide D/E Ratio
for Laboratory Corporation of America Holdings.

Provide D/A Ratio
for Laboratory Corporation of America Holdings.

Provide Interest Coverage Ratio
for Laboratory Corporation of America Holdings.

Provide Altman Z-Score Ratio
for Laboratory Corporation of America Holdings.

Provide Quick Ratio
for Laboratory Corporation of America Holdings.

Provide Current Ratio
for Laboratory Corporation of America Holdings.

Provide Cash Ratio
for Laboratory Corporation of America Holdings.

What is the historical Revenue growth
over the last 5 years for Laboratory Corporation of America Holdings?

What is the historical Net Income growth
over the last 5 years for Laboratory Corporation of America Holdings?

What is the current Free Cash Flow
of Laboratory Corporation of America Holdings?

Discuss the annual earnings per share (EPS)
trend over the past five years for Laboratory Corporation of America Holdings.

Business Breakdown

Laboratory Corporation of America Holdings, commonly referred to as LabCorp, has established itself as a leader in the biomedical testing and diagnostics industry. Founded in 1971, the company operates with a mission to improve health and improve lives by providing critical laboratory services to healthcare providers, pharmaceutical companies, and patients. LabCorp offers a comprehensive range of tests, encompassing everything from routine blood work to complex genomic testing. This diverse portfolio positions LabCorp to benefit from the growing demand for diagnostic services, particularly as healthcare continues to evolve toward precision medicine and personalized care. For investors, LabC...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Laboratory Corporation of America Holdings

Current Assets 4.9B
Cash & Short-Term Investments 1.5B
Receivables 2.2B
Other Current Assets 1.2B
Non-Current Assets 13.7B
Long-Term Investments 16.9m
PP&E 3.1B
Intangibles 10B
Other Non-Current Assets 612.6m
Current Liabilities 3.4B
Accounts Payable 660.9m
Accrued Liabilities 941.8m
Other Current Liabilities 1.8B
Non-Current Liabilities 7B
Long-Term Debt 5.4B
Other Non-Current Liabilities 1.6B
Efficiency

Earnings Waterfall
Laboratory Corporation of America Holdings

Revenue
12.7B USD
Cost of Revenue
-9.2B USD
Gross Profit
3.5B USD
Operating Expenses
-2.4B USD
Operating Income
1.1B USD
Other Expenses
-701.1m USD
Net Income
435.5m USD

Free Cash Flow Analysis
Laboratory Corporation of America Holdings

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Labcorp's Q3 revenue rose to $3.3 billion, a 7.4% increase, driven by 8.9% growth in Diagnostics and strong Central Laboratory performance. Adjusted EPS of $3.50 marks a 4% year-over-year rise. The company anticipates full-year revenue growth of 6.6% to 7.3%, with Diagnostics expected to grow by 7.2% to 7.8%. Biopharma revenue is projected at 4.7% to 5.6%. Notably, cost-saving initiatives are on track to deliver $100 million to $125 million in savings. A 2.4x net debt to trailing EBITDA ratio reflects financial positioning for future growth through strategic acquisitions.

What is Earnings Call?
Fundamental Scores

LH Profitability Score
Profitability Due Diligence

Laboratory Corporation of America Holdings's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Gross Profit
Positive 3-Year Average ROE
Positive Operating Income
50/100
Profitability
Score

Laboratory Corporation of America Holdings's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

LH Solvency Score
Solvency Due Diligence

Laboratory Corporation of America Holdings's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
46/100
Solvency
Score

Laboratory Corporation of America Holdings's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LH Price Targets Summary
Laboratory Corporation of America Holdings

Wall Street analysts forecast LH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LH is 269.01 USD with a low forecast of 233.31 USD and a high forecast of 307.65 USD.

Lowest
Price Target
233.31 USD
3% Downside
Average
Price Target
269.01 USD
12% Upside
Highest
Price Target
307.65 USD
28% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for LH?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Nov 24, 2024
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Shareholder Yield

Current shareholder yield for LH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

LH News

Other Videos

Profile

Laboratory Corporation of America Holdings Logo
Laboratory Corporation of America Holdings

Country

United States of America

Industry

Health Care

Market Cap

20.1B USD

Dividend Yield

1.2%

Description

Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 75,500 full-time employees. The Company’s business segments include Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). Through its Dx and DD segments, the Company provides diagnostic, drug development and technology enabled solutions. The firm also supports clinical trial activity in approximately 100 countries through its industry central laboratory, preclinical, and clinical development businesses. Dx segment operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. DD segment, which operates on a global scale. The firm serves a range of customers, including doctors, hospitals, pharmaceutical companies, researchers, governmental agencies, physicians and other healthcare providers. The company also helps in delivering non-clinical testing services.

Contact

NORTH CAROLINA
Burlington
358 S Main St
+13362291127.0
www.labcorp.com

IPO

1991-04-24

Employees

75 500

Officers

President, CEO & Chairman
Mr. Adam H. Schechter
CFO & Executive VP
Mr. Glenn A. Eisenberg
Executive VP, President of Diagnostics Laboratories & COO
Mr. Mark S. Schroeder
EVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer
Dr. Brian J. Caveney J.D., M.D., M.P.H.
Executive VP & Chief Human Resources Officer
Ms. Anita Z. Graham
Senior VP & Chief Accounting Officer
Mr. Peter J. Wilkinson
Show More
Executive VP and Chief Information & Technology Officer
Mr. Lance V. Berberian
Vice President of Investor Relations
Christin O'Donnell
Executive VP, Chief Legal Officer & Corporate Secretary
Ms. Sandra D. van der Vaart J.D.
Executive VP & Chief Marketing Officer
Ms. Amy B. Summy
Show Less

See Also

Discover More
What is the Intrinsic Value of one LH stock?

The intrinsic value of one LH stock under the Base Case scenario is 259.89 USD.

Is LH stock undervalued or overvalued?

Compared to the current market price of 239.67 USD, Laboratory Corporation of America Holdings is Undervalued by 8%.

Back to Top